loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Vesatolimod, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Vesatolimod

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    2D Structure
    1. Also known as: Gs-9620, 1228585-88-3, Gs9620, Vesatolimod [inn], 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5h)-one, 8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5h)-one
    Molecular Formula
    C22H30N6O2
    Molecular Weight
    410.5  g/mol
    InChI Key
    VFOKSTCIRGDTBR-UHFFFAOYSA-N
    FDA UNII
    O8M467C50G
    Vesatolimod has been used in trials studying the treatment of Hepatitis B and Chronic Hepatitis B.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one
    2.1.2 InChI
    InChI=1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26)
    2.1.3 InChI Key
    VFOKSTCIRGDTBR-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N
    2.2 Other Identifiers
    2.2.1 UNII
    O8M467C50G
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5h)-pteridinone

    2. Gs-9620

    2.3.2 Depositor-Supplied Synonyms

    1. Gs-9620

    2. 1228585-88-3

    3. Gs9620

    4. Vesatolimod [inn]

    5. 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5h)-one

    6. 8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5h)-one

    7. Gs 9620

    8. Chembl2424780

    9. O8m467c50g

    10. Mfcd25372045

    11. 4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one

    12. 6(5h)-pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-((3-(1-pyrrolidinylmethyl)phenyl)methyl)-

    13. 4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one

    14. Unii-o8m467c50g

    15. Vesatolimod (usan/inn)

    16. Vesatolimod [usan:inn]

    17. Vesatolimod [usan]

    18. Vesatolimod [who-dd]

    19. Schembl10083191

    20. Dtxsid40153741

    21. Hms3750i03

    22. Amy41043

    23. Bcp08305

    24. Ex-a2065

    25. Bdbm50440284

    26. S7221

    27. Zinc95616590

    28. Akos025290740

    29. Ccg-268776

    30. Cs-1352

    31. Db12687

    32. Sb16757

    33. Ncgc00390283-01

    34. Ncgc00390283-02

    35. Ncgc00390283-03

    36. Ac-30275

    37. As-74316

    38. Da-33595

    39. Hy-15601

    40. Sy028554

    41. Ft-0721305

    42. D11003

    43. Q27285487

    44. 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5h)-pteridinone

    45. 4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5h)-pteridinone

    46. 4-amino-2-butoxy-8-((3-((pyrrolidin-1-yl)methyl)phenyl)methyl)-7,8-dihydropteridin-6(5h)-one

    47. 4-amino-2-butoxy-8-({3-[(pyrrolidin-1-yl)methyl]phenyl}methyl)-5,6,7,8-tetrahydropteridin-6-one

    48. 9jr

    2.4 Create Date
    2010-07-19
    3 Chemical and Physical Properties
    Molecular Weight 410.5 g/mol
    Molecular Formula C22H30N6O2
    XLogP32.7
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count8
    Exact Mass410.24302422 g/mol
    Monoisotopic Mass410.24302422 g/mol
    Topological Polar Surface Area96.6 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity558
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antiviral Agents

    Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

    Post Enquiry
    POST ENQUIRY